Kaul, G.; Akhir, A.; Shukla, M.; Shafi, H.; Akunuri, R.; Pawar, G.; Ghouse, M.; Srinivas, N.; Chopra, S.
Microbiology Spectrum e05031-22 (2023)
Lescouzères, L.; Hassen‐Khodja, C.; Baudot, A.; Bordignon, B.; Bomont, P.
EMBO Molecular Medicine e16267 (2023)
Affecting the nervous system, GAN starts in infancy with motor deficits that rapidly evolve toward total loss of ambulation. Using the gan zebrafish model that reproduces the loss of motility as seen in patients, we conducted the first pharmacological screening for the GAN pathology. Here, we established a multilevel pipeline to identify small molecules restoring both the […]
Masson, S. W. C.; Madsen, S.; Cooke, K. C.; Potter, M.; Vegas, A. D.; Carroll, L.; Thillainadesan, S.; Cutler, H. B.; Walder, K. R.; Cooney, G. J.; Morahan, G.; Stöckli, J.; James, D. E.
Elife RP86961 (2023)
‘Diversity Outbred in Australia (DOz)’ is a population of genetically unique mice with profound metabolic heterogeneity. We leveraged this variance to explore skeletal muscle’s contribution to whole-body insulin action through metabolic phenotyping and skeletal muscle proteomics of 215 DOz mice. Linear modelling identified 553 proteins that associated with whole-body insulin sensitivity (Matsuda Index) including regulators […]
Papandreou, A.; Singh, N.; Gianfrancesco, L.; Budinger, D.; Barwick, K.; Agrotis, A.; Luft, C.; Shao, Y.; Lenaerts, A.-S.; Gregory, A.; Jeong, S. Y.; Hogarth, P.; Hayflick, S.; Barral, S.; Kriston-Vizi, J.; Gissen, P.; Kurian, M. A.; Ketteler, R.
bioRxiv 556416 (2023)
The mechanisms linking autophagy, iron overload and neurodegeneration in BPAN are poorly understood and, as a result, there are currently no disease-modifying treatments for this progressive disorder. We have developed a patient-derived, induced pluripotent stem cell (iPSC)-based midbrain dopaminergic neuronal cell model of BPAN (3 patient, 2 age-matched controls and 2 isogenic control lines) which […]
Sadahiro, Y.; Nishimura, S.; Hitora, Y.; Tsukamoto, S.
J Nat Prod (2023)
The accumulation and aggregation of IDPs are considered to be the etiology of neurodegenerative diseases. Notably, the 20S proteasome has a cylindrical structure, and its gate on the α-ring is closed in the inactive form. The compounds that open the gate promote the degradation of IDPs and prevent their accumulation, and therefore, such compounds may […]
Herzig, S.; Li, L.; Jiménez-Sánchez, C.; Martinou, J.-C.; Maechler, P.
Biochim Biophys Acta Gen Subj 130492 (2023)
This carrier is at the interface between glycolysis and mitochondrial metabolism and plays an essential role in hepatic glucose production.
Parent, C.; Melayil, K. R.; Zhou, Y.; Aubert, V.; Surdez, D.; Delattre, O.; Wilhelm, C.; Viovy, J.-L.
Lab Chip 5139–5150 (2023)
Microfluidics-based approaches can be powerful tools towards such biomimetic systems, but often require high-end complicated and expensive processes and equipment for microfabrication. Herein, a drug screening platform is proposed, minimizing technicality and manufacturing steps. It provides an alternate way of spheroid generation in droplets in tubes. Droplet microfluidics then elicit multiple droplets merging events at […]
García-Barbazán, I.; Torres-Cano, A.; García-Rodas, R.; Sachse, M.; Luque, D.; Megías, D.; Zaragoza, O.
mBio e02549-23 (2023)
This yeast can form the so-called titan cells in vivo, which are cells of an abnormally larger size due to an increase in both the capsule and the cell body size (total size reaching between 50–70 μm). This phenomenon can be partially reproduced in vitro to obtain cells of an intermediate size (25–30 μm), which […]
DiCesare, S. M.; Ortega, A. J.; Collier, G. E.; Daniel, S.; Thompson, K. N.; McCoy, M. K.; Posner, B. A.; Hulleman, J. D.
bioRxiv December 15 p 2023.12.14.571757 (2023)
To identify new small molecules that reduce F3 production from retinal pigmented epithelium (RPE) cells, we knocked-in a luminescent peptide tag (HiBiT) into the endogenous F3 locus which enabled simple, sensitive, and high throughput detection of the protein. The GSK3 inhibitor, CHIR99021 (CHIR), significantly reduced F3 burden (expression, secretion, and intracellular levels) in immortalized RPE […]
Fares, J.; Petrosyan, E.; Kanojia, D.; Dmello, C.; Cordero, A.; Duffy, J. T.; Yeeravalli, R.; Sahani, M. H.; Zhang, P.; Rashidi, A.; Arrieta, V. A.; Ulasov, I.; Ahmed, A. U.; Miska, J.; Balyasnikova, I. V.; James, C. D.; Sonabend, A. M.; Heimberger, A. B.; Lesniak, M. S
J Clin Invest e161142 (2023)
Using a CNS small-molecule inhibitor library of 320 agents known to be blood-brain barrier permeable and approved by the FDA, we interrogated breast cancer brain metastasis vulnerabilities to identify an effective agent. Metixene, an antiparkinsonian drug, was identified as a top therapeutic agent that was capable of decreasing cellular viability and inducing cell death across […]
